Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
In re TerraVia Holdings, Inc.
Case Number:
3:16-cv-06633
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
-
March 02, 2022
Ex-Biotech Execs Ink $2.5M Deal To End Investor Suit
Investors in defunct biotech company TerraVia Holdings Inc. have inked a $2.5 million deal to end claims that the company and its executives concealed reports linking the company's algae ingredients to gastrointestinal distress.
-
May 13, 2020
TerraVia Investors Seek Certification In Stock Drop Suit
Investors of bankrupt biotech company TerraVia Holdings Inc. urged a California federal court Tuesday to certify their class in a lawsuit against former executives that alleges they lied about the company's edible algae products, causing the stock price to drop.
-
February 05, 2020
Algae Supplier Execs Must Face Investors' Trimmed Claims
A California federal judge pared down claims Tuesday against former executives of a biotechnology company but gave investors a chance to revise their accusations that the company told lies about its edible algae products that caused a drop in its stock price.
-
December 04, 2018
TerraVia Says Investors' Stock-Drop Action Baseless
Bankrupt algae-to-food developer TerraVia Holdings Inc. has asked a California federal court to dismiss a proposed stock-drop class action claiming the company concealed reports that consumers became ill after eating food containing its ingredients, saying there's no evidence its products caused the reactions.